(Q39878372)

15 September 2017

title

A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost (English)

1 reference

15 September 2017

Paola Caramaschi

1

1 reference

15 September 2017

Nicola Martinelli

2

1 reference

15 September 2017

Alessandro Volpe

3

1 reference

15 September 2017

Sara Pieropan

4

1 reference

15 September 2017

Ilaria Tinazzi

5

1 reference

15 September 2017

Giuseppe Patuzzo

6

1 reference

15 September 2017

Helal Mahamid

7

1 reference

15 September 2017

Lisa Maria Bambara

8

1 reference

15 September 2017

Domenico Biasi

9

1 reference

15 September 2017

publication date

20 March 2009

1 reference

15 September 2017

published in

Clinical Rheumatology

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

807-813

1 reference

Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study

15 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-009-1155-6

Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-009-1155-6

Vascular damage from smoking: disease mechanisms at the arterial wall

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-009-1155-6

Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results

21 January 2018

1 reference

12 December 2020

Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules

1 reference

12 December 2020

Macrovascular disease and systemic sclerosis

1 reference

12 December 2020

Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis

1 reference

12 December 2020

Mortality and prognostic factors in Spanish patients with systemic sclerosis

1 reference

12 December 2020

Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.

1 reference

12 December 2020

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

1 reference

12 December 2020

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Cytokine production in scleroderma patients: effects of therapy with either iloprost or nifedipine

1 reference

12 December 2020

Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.

1 reference

12 December 2020

Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy

1 reference

12 December 2020

Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

1 reference

12 December 2020

Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis

1 reference

12 December 2020

Increased prevalence of symptomatic macrovascular disease in systemic sclerosis

1 reference

12 December 2020

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis

1 reference

12 December 2020

Assessment of skin, joint, tendon and muscle involvement.

1 reference

12 December 2020

Digital ulcers in patients with systemic sclerosis

1 reference

12 December 2020

Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis.

1 reference

12 December 2020

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases

1 reference

12 December 2020

Tissue-type plasminogen activator and von Willebrand factor plasma levels as markers of endothelial involvement in patients with Raynaud's phenomenon

1 reference

12 December 2020

Patient perception of UK scleroderma services--results of an anonymous questionnaire

1 reference

12 December 2020

Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia

1 reference

12 December 2020

Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis

1 reference

12 December 2020

10.1007/S10067-009-1155-6

Identifiers

DOI

1 reference

release_cukjtcos2rbxxffbgbax5xp64a

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cukjtcos2rbxxffbgbax5xp64a

24 November 2022

mapped directly with Wikidata item

1 reference